On November 28th, the Biomedical Translational Research Center (BioTReC) of Academia Sinica and Moderna Taiwn Taiwan held the "2025 Moderna Taiwan mRNA Foresight Innovation Award" ceremony and award-winning project presentation at the National Biotechnology Research Park. Ever-Supreme's allogeneic CAR-γδ T cell CAR001 therapy for relapsed/refractory solid tumors received unanimous recognition from the judges. The project continues to innovate and develop, benefiting more patients in need, through an important exchange platform provided by industry, academia, research, and medicine.
